Grupo de Inversiones Suramericana S.A. (hereinafter "Grupo SURA” or the "Company") hereby announces that today, it has issued its financial statements for the second quarter of this year. In said statements, as of June 1, 2024 onwards, EPS SURA^[1] shall not be consolidated and this investment shall be categorized as a financial instrument measured at fair value with changes recognized in other comprehensive income.

This new accounting treatment for EPS SURA comes within the framework for the interpretation and scope of international financial standards, especially IFRS 10, as applicable to consolidated financial statements, since control over the stake in said investment is construed to be lost, this in keeping with the Progressive Dismantling Program -PDP- filed before the Colombian Superintendence of Health Care on May 28, 2024, as duly announced to the market.

This decision does not impact Grupo SURA´s  sound position, solvency and liquidity as well as  those of its subsidiary Suramericana, considering that EPS SURA has allocated 100% of the profits obtained over the last 15 years to bolstering its equity and, therefore, has not provided any dividends during this period. Said deconsolidation is a purely accounting matter that does not affect EPS SURA's compliance with its obligations to its employees, users, members and suppliers. 

For more information, please refer to the Relevant Information published today by our subsidiary Suramericana S.A., as well as to Notes 2.2.2 and 3 of Grupo SURA's consolidated and separate financial statements, respectively.

[1] EPS Suramericana S.A. ("EPS SURA") is a subsidiary of Grupo SURA as well as Suramericana S.A.